This has led to the hope that similar products may be developed for hMPV, and Moderna has recently started trials into a mRNA hMPV vaccine. There are no treatments that have been clearly demonstrated ...

There is no evidence yet that the outbreak is extraordinary yet and Chinese officials have pushed back against claims of yet another pandemic.

Moderna (NASDAQ:MRNA – Free Report) had its price objective decreased by Evercore ISI from $60.00 to $50.00 in a research ...

Last summer, scientists at the University of Oxford launched a clinical trial of a combined RSV and hMPV vaccine in partnership with Moderna, and Andrew Pollard, a professor of infection and ...

Most children have had HMPV by the time they reach the age of ... There’s currently no cure or vaccine for the disease, though Moderna, the maker of a COVID-19 vaccine, is working to produce ...

Human metapneumovirus (HMPV) is a commonly found virus that can cause respiratory illness. Although it typically has no symptoms in healthy people, it can cause serious sickness in older adults, those ...

Authorities in China said they are monitoring cases of human metapneumovirus, or HMPV, after a reported increase inside the country, according to Reuters. Although cases are increasing at a rapid ...

Research analysts at Leerink Partnrs issued their Q4 2025 earnings estimates for Moderna in a research note issued to ...

HMPV commonly circulates during respiratory virus season, experts say. Chinese health officials are reportedly monitoring an increase in cases of human metapneumovirus (HMPV). There is currently ...

As rates of human metapneumovirus (HMPV) have risen in China, other countries have begun reporting cases of the virus. HMPV is a virus that presents symptoms similar to the cold, flu or COVID-19 ...

A reported increase in cases of the respiratory virus human metapneumovirus (HMPV) in China has caused alarm on social media. Photos and videos of crowded hospitals shared online have many people — ...